MDx Firms Get $9M in NCI Bridge Grants | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Cancer Institute has awarded nearly $9 million in new Small Business Innovation Research grants to the biomarker-based and molecular diagnostic cancer testing companies 20/20 GeneSystems, AmberGen, and Advanced Cell Diagnostics (ACD).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: tool to discover copy number variants, single-nucleus RNA sequencing study of myoblasts, and more.

A study of Tasmanian devil genomes suggests they are evolving resistance to devil facial tumor disease.

Theranos has withdrawn its request for emergency clearance of a Zika virus blood test, according to the Wall Street Journal.

An assistant professor who was fired from Mount Sinai School of Medicine has allegedly shot the school's dean, the New York Times reports.